Preparative purification of antiamyloidogenic stilbenoids from Vitis vinifera (Chardonnay) stems by centrifugal partition chromatography

Five stilbenoids, E-resveratrol, E-piceatannol, (+) E-(ɛ)-viniferin, (+)-ampelopsin A and vitisin C were isolated from methyl tert-butyl ether (M tBE) stem extract of Vitis vinifera (Chardonnay cv). Their purification on a preparative scale was obtained by centrifugal partition chromatography (CPC)...

Full description

Saved in:
Bibliographic Details
Published in:Journal of chromatography. B, Analytical technologies in the biomedical and life sciences Vol. 877; no. 10; pp. 1000 - 1004
Main Authors: Zga, N., Papastamoulis, Y., Toribio, A., Richard, T., Delaunay, J.C., Jeandet, P., Renault, J.H., Monti, J.P., Mérillon, J.M., Waffo-Téguo, P.
Format: Journal Article
Language:English
Published: Amsterdam Elsevier B.V 01-04-2009
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Five stilbenoids, E-resveratrol, E-piceatannol, (+) E-(ɛ)-viniferin, (+)-ampelopsin A and vitisin C were isolated from methyl tert-butyl ether (M tBE) stem extract of Vitis vinifera (Chardonnay cv). Their purification on a preparative scale was obtained by centrifugal partition chromatography (CPC) using quaternary Arizona solvent systems composed of n-heptane/ethyl acetate/methanol/water. We tested 23 Arizona solvent systems to partition the extract and found that systems K and M (Hept/EtOAc/MeOH/water, 1:2:1:2 and 5:6:5:6, respectively; v/v) were the best to separate the stilbenes mentioned above. This support-free liquid–liquid chromatographic procedure made it possible to isolate ampelopsin A from V. vinifera for the first time. The antiamyloidogenic activity of the isolated stilbenes was evaluated versus β-amyloid fibrils. E-resveratrol and (+)-ampelopsin A were found to be the most active compounds with 63 and 46% inhibition at 10 μM, respectively. These findings suggest that E-resveratrol and (+)-ampelopsin A may function as attractive new candidates for protecting against brain cell dysfunction in vivo in AD by inhibiting the aggregation of Aβ.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:1570-0232
1873-376X
DOI:10.1016/j.jchromb.2009.02.026